Russia cancer vaccine could receive approval by August allowing treatment to begin the head of the Gamaleya Research ...

Meet the woman leading vaccine innovation in Senegal to fight Rift Valley fever and empower Africa’s next generation of ...

Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.

Russia’s Gamaleya Research Institute, known for developing the Sputnik V COVID-19 vaccine, is close to gaining regulatory approval for a personalized mRNA cancer vaccine. According to the institute’s ...

New research reveals that sunburn may be caused by RNA damage, not DNA, challenging long-held beliefs about UV exposure ...

Companies including Moderna and Pfizer are working on mRNA vaccines for bird flu ... whether the virus is a common seasonal ...

MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to ...

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu.

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

Companies including Moderna and Pfizer are working on mRNA vaccines for bird flu ... seasonal strain or a novel version like H5N1, he explained. Such testing should ideally be completed within ...

Legislation that would block hospitals from transfusing blood containing COVID-19 antibodies or “synthetic mRNA” would ...